N-acetyltransferase 2 influences cancer prevalence in hMLH1/hMSH2 mutation carriers

Cancer Research

Volumn 59, Issue 13, 1999, Pages 3038-3040

  Heinimann, Karl ^a,b   Scott, Rodney J ^e   Chappuis, Pierre ^c   Weber, Walter ^a,b   Müller, Hansjakob ^a,b   Dobbie, Zuzana ^a,b   Hutter, Pierre ^d  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^c UNIVERSITY HOSPITAL   (Switzerland)

^d Institut Central des Hopitaux Valaisans   (Switzerland)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE;

ACETYLATOR PHENOTYPE; ADULT; ARTICLE; BASE MISPAIRING; COLORECTAL CANCER; DNA REPAIR; FEMALE; GENE MUTATION; GENOTYPE; HETEROZYGOTE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGE FACTORS; ARYLAMINE N-ACETYLTRANSFERASE; BASE PAIR MISMATCH; CARRIER PROTEINS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA-BINDING PROTEINS; FEMALE; GENOTYPE; HETEROZYGOTE DETECTION; HUMANS; MALE; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PHENOTYPE; PREVALENCE; PROTO-ONCOGENE PROTEINS; SWITZERLAND;

EID: 0033168092     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Aaltonen, L. A., Salovaara, R., Kristo, P., Canzian, F., Hemminki, A., Peltomaki, P., Chadwick, R. B., Kaariainen, H., Eskelinen, M., Jarvinen, H., Mecklin, J. P., and de la Chapelle, A. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N. Engl. J. Med., 338: 1481-1487, 1998.
2. Lynch, H. T. and Smyrk, T. An update on Lynch syndrome. Curr. Opin. Oncol., 10: 349-356, 1998.
3. Peltomaki, P. and Vasen, H. F. Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology, 113: 1146-1158, 1997.
4. Lin, K. M., Shashidharan, M., Thorson, A. G., Tement, C. A., Blatchford, G. J., Christensen, M. A., Watson, P., Lemon, S. J., Franklin, B., Karr, B., Lynch, J., and Lynch, H. T. Cumulative incidence of colorectal and extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal cancer. J. Gastrointest. Surg., 2:67-71, 1998.
5. Smith, G., Stanley, L. A., Sim, E., Strange, R. C., and Wolf, C. R. Metabolic polymorphisms and cancer susceptibility. Cancer Surv., 25: 27-65, 1995.
6. Doll, R. and Peto, R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. Natl. Cancer Inst., 66: 1191-1308, 1981.
7. Buerstedde, J. M., Alday, P., Torhorst, J., Weber, W., Muller, H., and Scott, R. Detection of new mutations in six out of 10 Swiss HNPCC families by genomic sequencing of the HMSH2 and hMLH1 genes. J. Med. Genet., 32: 909-912, 1995.
8. Hutter, P., Couturier, A., Scott, R. J., Alday, P., Delozier-Blanchet, C., Cachat, F., Antonarakis, S. E., Joris, F., Gaudin, M., D'Amato, L., and Buerstedde, J. M. Complex genetic predisposition to cancer in an extended HNPCC family with an ancestral hMLH1 mutation. J. Med. Genet., 33: 636-640, 1996.
9. Heinimann, K., Muller, H., Weber, W., and Scott, R. J. Disease expression in Swiss hereditary non-polyposis colorectal cancer (HNPCC) kindreds. Int. J. Cancer, 74: 281-285, 1997.
10. Hutter, P., Couturier, A., Membrez, V., Joris, F., Sappino, A. P., and Chappuis, P. O. Excess of hMLH1 germline mutations in Swiss families with hereditary non-polyposis colorectal cancer. Int. J. Cancer, 78: 680-684, 1998.
11. Heinimann, K., Scott, R. J., Buerstedde, J. M., Weber, W., Siebold, K., Attenhofer, M., Muller, H. J., and Dobbie, Z. Influence of selection criteria on mutation detection in hereditary nonpolyposis colorectal cancer. Cancer (Phila.), in press, 1999.
12. Miller, S. A., Dykes, D. D., and Polesky, H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res., 16: 1215, 1988.
13. Smith, C. A., Wadelius, M., Gough, A. C., Harrison, D. J., Wolf, C. R., and Rane, A. A simplified assay for the arylamine N-acetyltransferase 2 polymorphism validated by phenotyping with isoniazid. J. Med. Genet., 34: 758-760, 1997.
14. Lin, H. J., Han, C. Y., Lin, B. K., and Hardy, S. Slow acetylator mutations in the human polymorphic N-acetyltransferase gene in 786 Asians, blacks, Hispanics, and whites: application to metabolic epidemiology. Am. J. Hum. Genet., 52: 827-834, 1993.
15. Fryer, A. A., Zhao, L., Alldersea, J., Pearson, W. R., and Strange, R. C. Use of site-directed mutagenesis of allele-specific PCR primers to identify the GSTM1 A, GSTM1 B, GSTM1 A, B, and GSTM1 null polymorphisms at the glutathione S-transferase, GSTM1 locus. Biochem. J., 295: 313-315, 1993.
16. Pemble, S., Schroeder, K. R., Spencer, S. R., Meyer, D. J., Hallier, E., Bolt, H. M., Ketterer, B., and Taylor, J. B. Human glutathione S-transferase θ (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem. J., 300: 271-276, 1994.
17. Chenevix-Trench, G., Young, J., Coggan, M., and Board, P. Glutathione S-transferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onset. Carcinogenesis (Lond.), 16: 1655-1657, 1995.
18. Lynch, H. T., Smyrk, T., and Lynch, J. F. Overview of natural history, pathology, molecular genetics and management of HNPCC (Lynch Syndrome). Int. J. Cancer, 69: 38-43, 1996.
19. Badawi, A. F., Hirvonen, A., Bell, D. A., Lang, N. P., and Kadlubar, F. F. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. Cancer Res., 55: 5230-5237, 1995.
20. Hubbard, A. L., Harrison, D. J., Moyes, C., Wyllie, A. H., Cunningham, C., Mannion, E., and Smith, C. A. N-acetyltransferase 2 genotype in colorectal cancer and selective gene retention in cancers with chromosome 8p deletions. Gut, 41: 229-234, 1997.